Objective: To report the phenotypic characterization of monozygotic twins with mutations encoding progranulin (PGRN).
index scores were converted to T scores (which have a mean of 50 and SD of 10) for comparison.
Neuroimaging. Each twin underwent structural MRI and fluorodeoxyglucose PET (FDG-PET) imaging of the brain. MRI scans (GE Healthcare, Waukesha, WI) were obtained at 3 T with multiple sequence types including 3-dimensional T1weighted magnetization-prepared rapid gradient echo, fluidattenuation inversion recovery, and long echo time gradient echo. For PET images, FDG was injected IV; then after a 30minute period, a helical CT image was obtained for attenuation correction and an 8-minute 3-dimensional scan immediately followed. Three-dimensional stereotactic surface projections were derived from the FDG-PET images, and these were compared with those of age-matched controls, yielding a 3-dimensional z score metabolic map (Cortex ID; GE Healthcare). 9
Progranulin ELISA analyses in plasma. Plasma progranulin levels were quantified using a commercially available ELISA (R&D Systems, Minneapolis MN) and were compared with data in neurologically normal control subjects.
RESULTS Clinical and neuropsychological data.
Twin 1 (proband). The proband, who has a PhD, was first encountered at the age of 62 with a 12-month history of paranoia, concerns about spousal infidelity, and impulsive spending habits, as well as shortterm memory difficulties, language comprehension difficulties, mild apathy, and difficulty with work performance. At the time of his initial evaluation, he was no longer working because of cognitive decline, yet he reported no cognitive difficulties. In addition, his driver's license had been revoked because of a traffic infraction. He showed little concern for that event and his poor judgment. Instrumental activities of daily living were minimally affected. Initial evaluation revealed a mild fluent aphasia with dysnomia, circumlocution, and learning and memory deficits. There was no evidence of visuospatial difficulties nor prosopagnosia. Formal neuropsychological testing highlighted a large discrepancy in performance and verbal IQ (performance IQ Ͼ verbal IQ) along with severe verbal learning and memory deficits, moderate expressive language deficits, and average executive functions, but retention of visuospatial abilities (figure 1 and appendix e-1 on the Neurology ® Web site at www.neurology.org). Genetic testing was performed, and a previously reported pathogenic 4-bp deletion (c.388_391delCAGT) in exon 4 of PGRN was identified. 1 Twin 2. This right-handed man with a master's level education had a history of head trauma as a younger adult and may have experienced a brief period of anoxia during a cardiac ablation procedure at age 58. At the age of 59, he began to demonstrate personality changes with paranoia, concerns about spousal infidelity, impulsive spending habits, poor insight, and obsessional somatization regarding jaw and chest pain. At the age of 60 he underwent neuro-psychological testing (figure 1 and appendix e-1). Although initial IQ indices for verbal and performance measures were high average and without discrepancies, more extensive testing demonstrated deficiencies in learning and memory and language and executive function with spared visuospatial functioning. He subsequently began to demonstrate disinhibition in his personal and work relationships, resulting in legal difficulties. Within 12 to 18 months of behavioral changes, the patient began to demonstrate memory problems such as forgetting to pay bills. His speech became more tangential. He gained 50 pounds from overeating and demonstrated persistently limited insight into his deficiencies. He was forced to retire from his professional activities at the age of 61 because of cognitive difficulties.
MRI and FDG-PET data. MRI highlighted the asymmetric left hemisphere atrophy with temporal lobe predominance, and FDG-PET demonstrated an asymmetric temporal-parietal distribution of hypometabolism also involving the precuneus and caudate. The imaging findings were strikingly similar between the 2 subjects (figure 2).
Progranulin ELISA analyses in plasma data. Plasma progranulin analyses showed significantly reduced levels in both patients (twin 1: 11.6 ng/mL; twin 2: 15.6 ng/mL) compared with a series of 523 control individuals (average: 50.2 ng/mL; minimum 25.7 ng/mL).
DISCUSSION
In this monozygotic twin pair, there was general concordance in symptoms, age at onset, low plasma progranulin level, neuropsychological profile, and topography of findings on neuroimaging. Although there were some cognitive differences at the time of evaluation, these might reflect the differences between the time of onset and testing. The role of environmental influences is limited in some degree by the fact that both had pursued very similar occupational and cognitive pursuits in adulthood. This unique twin pair highlights the role of genetic determinism, even in the face of environmental differences, particularly in relation to the cortical asymmetry.
The findings in these twins also have intriguing implications for understanding the pathophysiology of PGRN mutations. The presumed mechanism for PGRN mutations is that haploinsufficiency results in a markedly reduced level of progranulin, yet how does a chronic low level of an important protein, which is presumably being produced and circulating in a generalized systemic manner including throughout the whole brain over decades, result in only a particular region in one side of the brain being affected? Interestingly, available studies with PGRN mutations suggest a greater asymmetry in atrophy and brain perfusion compared with sporadic behavioral variant FTD. 5, 7 Other affected members of a kindred with the same PGRN mutation typically exhibit various phenotypes ranging from Alzheimer-like dementia, FTD, and primary progressive aphasia, and therefore one could surmise that both genetic (the multitude of dissimilar polymorphisms across the genome) and environmental factors affect the topography of degeneration and hence the phenotype. As for the monozygotic twins with strikingly similar features, one could hypothesize that one or more of the identical non-PGRN genetic determinants could be driving the topography of degeneration, perhaps by making a particular set of neuronal networks more susceptible to neurodegeneration. 3, 5, 7, 10 Perhaps a similar genetic mechanism could explain the rare kindreds that have PGRN mutations with very similar phenotypes. 3, 7, 10 The hemispheric homology in our case of monozygotic twins may represent an endophenotype that reflects a cortical network susceptibility in combination with additional genetic contributions beyond the PGRN null mutation; this hypothesis warrants further investigation. Magnetic resonance (MR) and fluorodeoxyglucose (FDG) PET imaging MR and FDG-PET imaging of twin 1 at age 62 (A) and twin 2 at age 60 (B). Fluid-attenuation inversion recovery (FLAIR) MR imaging demonstrates asymmetric cerebral volume loss in the left hemisphere compared with the right hemisphere, most notable in the anterior temporal lobe. FDG-PET images demonstrate moderately severe left Ͼ Ͼ right temporal and mild to moderate left Ͼ Ͼ right parietal and frontal hypometabolism. Three-dimensional stereotactic surface projection (3D SSP) z score images demonstrate left medial frontal, temporal and parietal, and bilateral (left worse than right) posterior cingulate hypometabolism. Note the strikingly similar topography of brain hypometabolism demonstrated on the z score images.
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